Latest News

: European drugmakers including AstraZeneca pony up for U.S.-listed biopharmas

European drugmakers announced a trio of deals around a billion dollars each to buy U.S.-listed biopharmas at hefty premiums 

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Latest News